Clinical trials
Phase 3 Osteoporosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
179 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 10 |
| 2002 | 12 |
| 2003 | 15 |
| 2004 | 19 |
| 2005 | 14 |
| 2006 | 18 |
| 2007 | 11 |
| 2008 | 9 |
| 2009 | 11 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 150 |
| Terminated | 12 |
| Unknown status | 11 |
| Withdrawn | 5 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 17 |
| Novartis Pharmaceuticals | 13 |
| Eli Lilly and Company | 8 |
| Merck Sharp & Dohme LLC | 6 |
| Organon and Co | 6 |
| Novartis | 5 |
| Radius Health, Inc. | 5 |
| Alliance for Clinical Trials in Oncology | 4 |
| Shire | 4 |
| ETOP IBCSG Partners Foundation | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis | 179 |
| Bone Diseases, Metabolic | 40 |
| Osteoporosis, Postmenopausal | 24 |
| Breast Neoplasms | 13 |
| Fractures, Bone | 11 |
| Prostatic Neoplasms | 9 |
| Bone Diseases | 5 |
| Osteoporotic Fractures | 5 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus | 3 |
Trials
Showing 76 to 100 of 179. Each trial links to its page on Pharma Observatory.
79 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.